Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

6.2%

52 terminated/withdrawn out of 835 trials

Success Rate

88.1%

+1.6% vs industry average

Late-Stage Pipeline

11%

94 trials in Phase 3/4

Results Transparency

5%

19 of 384 completed trials have results

Key Signals

153 recruiting19 with results39 terminated13 withdrawn

Enrollment Performance

Analytics

N/A
263(50.7%)
Phase 2
91(17.5%)
Phase 1
65(12.5%)
Phase 4
54(10.4%)
Phase 3
40(7.7%)
Early Phase 1
6(1.2%)
519Total
N/A(263)
Phase 2(91)
Phase 1(65)
Phase 4(54)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (835)

Showing 20 of 835 trials
NCT07645625Phase 4Recruiting

Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer

Role: lead

NCT07643727Phase 1Not Yet Recruiting

Development of Fluorescent Lectin Tracers With Dedicated Technology for in Vivo Detection of Esophageal Dysplasia in Barrett Patients

Role: lead

NCT05864794Not ApplicableRecruiting

Value of Screening MRI Brain in Stage IV Non-small Cell Lung Cancer

Role: lead

NCT07632079Phase 2Recruiting

Hypofractionated Definitive Chemoradiotherapy for Oesophageal Cancer

Role: collaborator

NCT07629752Not Yet Recruiting

Immediate Loading of Implants in the Aesthetic Zone Using Three-dimensionally Printed Provisional Crowns: a 1-year Prospective Case Series Study

Role: lead

NCT07627269Not ApplicableNot Yet Recruiting

Late Scan Time-point Optimalisation of 18F-Fluoroestradiol for the Large Field-of-view (LAFOV) PET/CT Scanner.

Role: lead

NCT05186064Not ApplicableCompleted

Glioblastoma Targeted Treatment Option Maximization by WGS

Role: collaborator

NCT02516033Completed

Hybrid Atrial Fibrillation Ablation Registry

Role: lead

NCT05256199Not ApplicableActive Not Recruiting

Dutch Multidomain Lifestyle Intervention in Older Adults at Risk of Cognitive Decline

Role: collaborator

NCT05440812Not ApplicableCompleted

Improving Personal Recovery After Depression With a Blended Module (STAIRS)

Role: lead

NCT07304817Phase 2Recruiting

Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)

Role: lead

NCT07497724Active Not Recruiting

Odevixibat Outcomes in Patients With PFIC Versus an External Control Cohort (OvEC-PFIC)

Role: collaborator

NCT05546372Not ApplicableRecruiting

Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction Due to Perihilar Cholangiocarcinoma

Role: collaborator

NCT04502511Recruiting

Heterogeneity of Critical Illness: a Cohort Study

Role: lead

NCT03553069Completed

Simple Observational Critical Care Studies

Role: lead

NCT04460170Completed

COVID-19 Follow up Intensive Care Studies

Role: lead

NCT07606014Phase 2Recruiting

No Guts No Glory Probiotics

Role: lead

NCT07604727Not ApplicableNot Yet Recruiting

AV Nodal Ablation With Conduction System Pacing Versus Cardiac Resynchronization for Symptomatic Heart Failure Patients With Atrial Fibrillation

Role: lead

NCT07014423Not ApplicableCompleted

The Added Value of Three-dimensional Electroanatomic Mapping For Accurate Delivery Of Pulsed Field Ablation In The Pulmonary Veins Compared To Pulsed Field Ablation With Fluoroscopy And/Or Intracardiac Echocardiography Alone In The Treatment Of Atrial Fibrillation: MAP-PFA Study

Role: lead

NCT05374291Phase 3Enrolling By Invitation

The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD

Role: lead